Skip to content

PP&E (Net) at other companies

Immunome logo
ImmunomeIMNM
$17.08M+55.9%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$38M-17.4%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$112.79M-16.6%
WHW
Whitehawk Therapeutics, Inc. Common StockWHWK
$2K-92.0%

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+66.4%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's PP&E (net)?
OS Therapies (OSTX) reported PP&E (net) of $1.8K in Q1 2026.
How has OS Therapies's PP&E (net) changed year-over-year?
OS Therapies's PP&E (net) decreased by 60.8% year-over-year, from $4.58K to $1.8K.
What is the long-term trend for OS Therapies's PP&E (net)?
Over 2 years (2023 to 2025), OS Therapies's PP&E (net) has grown at a -44.4% compound annual growth rate (CAGR), from $8.05K to $2.49K.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.